Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Luminex’s xMAP multiplexing technology allows simultaneous analysis of up to 500 bioassays from a single sample. The company’s systems are widely used in clinical diagnostics, drug discovery/development, genetic analysis, public health labs, pharma companies, academic institutions, and more. Its technologies have received FDA clearances through partners for multiple diagnostic applications.
As of July 2021 it operates as a subsidiary of DiaSorin S.p.A.
Over its history it has placed thousands of systems globally.
No therapeutic clinical results—company focus is on enabling research/diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luminex.